Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2016-04-20 Interim / Quarterly Rep…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
First quarter report for 2016 and presentation for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive quarterly financial report for the first quarter of 2016. It includes detailed financial statements (Profit & Loss), management commentary on operational performance, geographic sales splits, balance sheet data, and forward-looking strategy. It is not an announcement of a report, but the report itself, containing substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). Q1 2016
2016-04-20 English
1. kvartals rapport 2016 og presentasjon for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive quarterly report for Medistim ASA for Q1 2016. It contains detailed financial statements (Profit and Loss, Balance Sheet), business segment updates, and strategic analysis. It is not a short announcement (it exceeds 11,000 characters) and provides substantive financial data, which distinguishes it from an Earnings Release (ER) or a Report Publication Announcement (RPA). Therefore, it is classified as an Interim/Quarterly Report. Q1 2016
2016-04-20 Norwegian
First quarter report for 2016 and presentation for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive quarterly report for Medistim ASA for Q1 2016. It contains detailed financial statements (Profit and Loss, Balance Sheet), business segment updates, and strategic analysis. It is not a short announcement (it exceeds 11,000 characters) and provides substantive financial data, which distinguishes it from an Earnings Release (ER) or a Report Publication Announcement (RPA). Therefore, it is classified as an Interim/Quarterly Report. Q1 2016
2016-04-20 English
1. kvartals rapport 2016 og presentasjon for Medistim ASA
Earnings Release Classification · 98% confidence The document text explicitly mentions "1. kvartals rapport 2016" (1st quarter report 2016) and provides key financial highlights (Revenue, EBIT, sales growth) typical of an earnings announcement. The length is very short (584 chars), suggesting it is the initial release of results rather than the comprehensive report itself. This aligns perfectly with the definition of an Earnings Release (ER), which covers periodical financial results (key highlights only). It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), but rather the initial summary. Q1 2016
2016-04-20 Norwegian
First quarter report for 2016 and presentation for Medistim ASA
Earnings Release Classification · 98% confidence The document explicitly mentions 'First quarter report for 2016' and provides key financial highlights (Sales, Operating profit, growth rates) typical of an earnings announcement. The length is very short (574 chars), suggesting it is a summary or release rather than the comprehensive report itself. This aligns perfectly with the definition of an Earnings Release (ER), which contains initial announcements of periodical financial results (key highlights only). It is not a full Interim Report (IR) given the brevity and focus on highlights. Q1 2016
2016-04-20 English
Nøkkelinformasjon ved kontantutbytte for Medistim ASA
Notice of Dividend Amount Classification · 99% confidence The document text explicitly details key information regarding a cash dividend ('kontantutbytte') for Medistim ASA. It lists the dividend amount (1.65 NOK per share), the ex-date (20. april 2016), record date, and payment date. This content directly corresponds to the definition of a Notice of Dividend Amount.
2016-04-19 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.